Search by Drug Name or NDC
NDC 68462-0387-30 solifenacin succinate 10 mg/1 Details
solifenacin succinate 10 mg/1
solifenacin succinate is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is SOLIFENACIN SUCCINATE.
MedlinePlus Drug Summary
Solifenacin (VESIcare) is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Solifenacin (VESIcare LS) is used to treat neurogenic detrusor overactivity (a bladder control condition caused by brain, spinal cord or nerve problem) in children 2 years of age and older. Solifenacin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
Related Packages: 68462-0387-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Solifenacin
Product Information
| NDC | 68462-0387 |
|---|---|
| Product ID | 68462-387_9cfcab1d-64ac-457b-979f-41cf6547a63a |
| Associated GPIs | 54100055200330 |
| GCN Sequence Number | 057983 |
| GCN Sequence Number Description | solifenacin succinate TABLET 10 MG ORAL |
| HIC3 | R1I |
| HIC3 Description | URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG. |
| GCN | 23277 |
| HICL Sequence Number | 026595 |
| HICL Sequence Number Description | SOLIFENACIN SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | solifenacin succinate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | solifenacin succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | SOLIFENACIN SUCCINATE |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209239 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0387-30 (68462038730)
| NDC Package Code | 68462-387-30 |
|---|---|
| Billing NDC | 68462038730 |
| Package | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-387-30) |
| Marketing Start Date | 2019-05-20 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.19886 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | SOLIFENACIN 10 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis